Genetic progression and divergence in pancreatic carcinoma

American Journal of Pathology

Volumn 156, Issue 6, 2000, Pages 2123-2133

  Yamano, Miki ^a   Fujii, Hiroaki ^b   Takagaki, Tetsuya ^b   Kadowaki, Naomi ^b   Watanabe, Hidenobu ^a   Shirai, Toshikazu ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CHROMOSOME LOSS; CLINICAL ARTICLE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS ISLET CELL HYPERPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0033888296     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65083-3     Document Type: Article

References (50)

1. Estimates of the worldwide frequency of sixteen major cancers in 1980
2. Japan pancreatic cancer registry: Current status
3. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
4. Ras gene mutations in intraductal papillary neoplasms of the pancreas. Analysis in five cases
5. Determination of pancreatic ductal carcinoma histogenesis by analysis of mucous quality and K-ras mutation
6. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
7. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation
8. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
9. Molecular genetics of exocrine pancreatic neoplasms
10. Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumor-suppressor genes
11. Pancreatic adenocarcinomas frequently show p53 gene mutations
12. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
13. Tumor-suppressive pathways in pancreatic carcinoma
14. Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas
15. Deletion and mutation analyses of the p16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas
16. Frequent somatic mutations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma
17. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p 16/MTS1 in pancreatic tumors
18. DPC4 gene in various tumor types
19. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
20. Homozygous deletion map at 18q21.1 in pancreatic cancer
21. Allelotype of pancreatic adenocarcinoma
22. Allelotype of pancreatic adenocarcinoma using xenograft enrichment
23. Genetic progression and heterogeneity in intraductal papillary- mucinous neoplasms of the pancreas
24. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer
25. K-ras mutations and alletic loss at 5q and 18q in the development of human pancreatic cancers
26. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer
27. Pancreatic duct hyperplasia and cancer
28. Relation of pancreatic duct hyperplasia to carcinoma
29. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases
30. The classification of pancreatic ductal epithelium according to atypia
31. Tumors of the pancreas
32. Review. Pathology of incipient pancreatic cancer
33. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor
34. Alterations in pancreatic, biliary, and breast carcinomas support: MKK4 as a genetically targeted tumor suppressor gene
35. Frequent somatic mutations of the APC gene in human pancreatic cancer
36. Abnormalities affecting the APC and MCC tumor suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer
37. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
38. Technical advance. Microclissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections
39. Technical advance. A high frequency of sequence alterations is due to formalin fixation of archival specimens
40. Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction
41. DNA damage promotes jumping between templates during enzymatic amplification
42. Genetic divergence in the clonal evolution of breast cancer
43. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast
44. Genetic alterations during colorectal-tumor development
45. Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas
46. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
47. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas
48. Frequency and types of point mutation at the 12th codon of the c-Ki- ras gene found in pancreatic cancers from Japanese patients
49. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas